RxGen is a preclinical CRO focused exclusively in vivo disease modeling and the application of related models of human physiology and disease to drug and device development. RxGen applies extensive expertise in many areas of therapeutic and diagnostic interest for which clinically relevant models are feasible, with a focus on ADMET studies and CNS, ophthalmic and metabolic disorders.